Faster full-body MRI scans with artificial intelligence
This study uses artificial intelligence to make high-field whole-body MRI scans faster and better. It may help improve cancer screening by producing clearer images in less time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You are scheduled for a whole-body MRI for cancer screening
- If you are male, the scan may focus on the prostate area
- You do not have claustrophobia (fear of enclosed spaces)
- You do not have metal implants that could affect the scan
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses whole-body MRI to see if it can find health issues early in people without symptoms. The goal is to learn if this scan can help predict clinically important conditions in routine preventive care.
This study uses whole-body MRI scans to see if they help monitor or diagnose cancer better. It may be an option if your doctor has already recommended this type of scan.
This study tests a new computer program that reads prostate MRI images to help doctors diagnose prostate cancer more accurately. It may help you by providing a clearer picture of your condition without extra tests.
This study tests a new, lower-strength MRI to see if it can give clearer images of the prostate, especially for men who have metal implants or who need a biopsy. It may help doctors monitor prostate health more safely and effectively.
This study is testing whether artificial intelligence can better predict prostate cancer by combining two types of scans (MRI and PSMA PET) along with your medical history, PSA, and biopsy results. If you have already had these scans and a biopsy, your information may help researchers develop a more accurate, non-invasive diagnostic tool.
This trial studies special MRI images to learn how well they can find prostate cancer before treatment. It may help doctors choose better next steps during biopsy or during active surveillance.
Hear when a new Prostate trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.